Risk for Benign Prostatic Hyperplasia Increased for Patients With Gout
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Jan. 31, 2024 -- Patients with gout, especially those younger than 60 years, have an increased risk for benign prostatic hyperplasia (BPH), according to a study published online Dec. 26 in Diagnostics.
Woo Jin Bang, from the Hallym University College of Medicine in Anyang, South Korea, and colleagues retrieved data from 514,866 Korean National Health Insurance Service-Health Screening Cohorts from 2002 to 2019 to examine the risk for BPH in patients with gout. Data were analyzed for 14,961 gout patients and 58,764 matched controls.
The researchers found that the incidence of BPH was 23.40 and 20.70 percent in gout and control participants, respectively. The hazard ratio for BPH was 1.13-fold higher for gout versus control patients, in the adjusted model. Among gout patients, those aged younger than 60 years had a higher hazard ratio for BPH compared with the age group 60 years and older (1.19 versus 1.07). A consistent risk for gout was seen according to various comorbidities.
"The elevated risk of BPH in gout patients was independent of lifestyle factors and comorbid conditions," the authors write. "Clinicians may need to consider the potentially increased risk of BPH when managing patients with gout and the need for early monitoring or intervention."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted January 2024
Read this next
Benign Prostatic Hyperplasia Risk Increased for Patients With Chronic Prostatitis
WEDNESDAY, April 3, 2024 -- Patients with chronic prostatitis (CP) have an increased risk for developing benign prostatic hyperplasia (BPH), according to a study published online...
Disparities in Transgender Prostate Screening Uptake Driven by Clinicians
FRIDAY, Feb. 23, 2024 -- Clinician recommendations are the most significant factor in driving prostate-specific antigen (PSA) screening in transgender women, according to a study...
SARS-CoV-2 Infection Linked to Incidence of BPH Complications
FRIDAY, Oct. 20, 2023 -- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with an increased incidence of benign prostatic hyperplasia (BPH)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.